Eupraxia Pharmaceuticals position history
The shares of Eupraxia Pharmaceuticals that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 225,600 shares, $1.5M, 0.28% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|